What are the standard first-line treatment options for Melanoma

Standard First-Line Treatment Options for Melanoma

The treatment approach for melanoma depends heavily on the stage of disease at diagnosis. Let me walk you through how doctors think about this and what options typically exist.

How Doctors Approach Melanoma Treatment

According to the NCCN Guidelines for Patients: Melanoma (2025), treatment decisions are based on whether the cancer is:

• Early stage (stages 0-2): localized to the skin
• Regional (stage 3): spread to nearby lymph nodes or skin
• Metastatic (stage 4): spread to distant parts of the body

The good news is that most melanomas are found in earlier stages, which are generally easier to treat.

---

First-Line Treatment by Stage

Early Stage Melanoma (Stages 0-2)

Surgery is the primary treatment. Doctors perform a procedure called excision — removing the melanoma tumor along with a margin of healthy skin around it to ensure all cancer cells are removed.

For some early-stage cases, this surgery alone may be sufficient, and patients move to follow-up care with regular skin exams.

Regional Melanoma (Stage 3)

When melanoma has spread to nearby lymph nodes or appears as satellite/in-transit tumors (cancer in lymph vessels near the original site), treatment options typically include:

Resectable disease (cancer that can be surgically removed):

• Surgery with complete excision to remove all disease
• T-VEC (talimogene laherparepvec) — an intralesional therapy that uses a modified virus to kill cancer cells directly at the tumor site
• Systemic therapy (drugs that travel through the bloodstream)
• Neoadjuvant systemic therapy — treatment given before surgery to shrink the cancer first

After surgery with no remaining cancer, preferred adjuvant (follow-up) therapy options include:

• Nivolumab (Opdivo) — an immunotherapy checkpoint inhibitor
• Pembrolizumab (Keytruda) — another immunotherapy checkpoint inhibitor
• Dabrafenib/trametinib — targeted therapy for patients with a BRAF V600 mutation

Metastatic Melanoma (Stage 4)

For melanoma that has spread to distant organs, systemic therapy becomes the primary approach, with options including immunotherapy and targeted therapy depending on specific tumor characteristics.

---

Understanding Immunotherapy (A Key First-Line Option)

Immunotherapy works by "releasing the brakes" on your immune system. According to NCCN Guidelines, checkpoint inhibitors like nivolumab and pembrolizumab block proteins that cancer cells use to hide from T cells (immune cells). This allows your body's immune system to recognize and attack the cancer.

These drugs are given as infusions (injected into a vein) every few weeks, or as a newer subcutaneous (under-the-skin) injection option.

---

Important Questions to Ask Your Care Team

1. What stage is my melanoma, and what does that mean for my treatment options?
2. Has my tumor been tested for BRAF mutations or other biomarkers? (This affects which targeted therapies might work)
3. Which first-line treatment do you recommend for my specific situation, and why?
4. What are the potential side effects of the treatment you're recommending?
5. Will I need adjuvant (follow-up) therapy after surgery, and if so, what type?
6. Are there clinical trials available that might be appropriate for my case?

---

Key Takeaway

Your oncologist will determine the most appropriate first-line treatment based on your melanoma's stage, specific characteristics (like BRAF mutation status), your overall health, and other individual factors. The NCCN Guidelines emphasize that early detection and treatment significantly improve outcomes, and more effective treatments have become available in recent years.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.